BDSX Biodesix, Inc.

NASDAQ
$24.00

Biodesix, Inc. (BDSX) is expected to report earnings on November 4, 2026, after the market close. The consensus earnings estimate is a loss of $0.74 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +10.3% since its last earnings release on August 5, 2026.

Biodesix Beat Expectations, Reaffirms
Wednesday, August 5, 2026 · 4:01 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 4
Wednesday · 4:00 PM ET
Earnings Whisper
-
vs ($0.74)
Rev est $27.63M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $23.61

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Biodesix, Inc.

Biodesix is a leading diagnostic company with a focus in lung disease. The Company develops diagnostic tests addressing important clinical questions by combining multi-omics through the power of artificial intelligence.

Sector

Healthcare

Industry

Medical Labs & Research